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[h1]Abstract 
[h2] Purpose 
The purpose of this review is to describe the epidemiology of out-of-hospital cardiac 
arrest (OHCA), disparities in organisation and outcome, recent advances in 
treatment and ongoing controversies. We also outline the standard of care that 
should be provided by the critical care specialist and propose future directions for 
cardiac arrest research. 
 
[h2] Methods 
Narrative review with contributions from international resuscitation experts 
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[h2] Results 
Although it is recognised that survival rates from OHCA are increasing there is 
considerable scope for improvement and many countries have implemented 
national strategies in an attempt to achieve this goal. More resources are required 
to enable high-quality randomised trials in resuscitation.  
 
[h2] Conclusion 
Increasing international collaboration should facilitate resuscitation research and 
knowledge translation. The International Liaison Committee on Resuscitation (ILCOR) 
has adopted a continuous evidence review process, which facilitate the 
implementation of resuscitation interventions proven to improve patient outcomes.  
 
[h1] Introduction  
Survival to hospital discharge rates following out-of-hospital cardiac arrest (OHCA) 
are increasing but remain in the range of 8–10% in many parts of the world. Higher 
survival rates are achieved in some centres that have optimised their local chain of 
survival. Strategies to increase rates of bystander CPR, increase the availability of 
public access automated defibrillators (AEDs), and to implement regional cardiac 
arrest networks will require collaboration with, and the engagement of, stakeholders. 
This review describes the epidemiology of OHCA, disparities in organisation and 
outcome, recent advances in treatment and ongoing controversies. We outline the 
standard of care that should be provided by the critical care specialist and propose 
future directions for cardiac arrest research. 
 
[h1] Cardiac arrest: epidemiology and general trends  
Incidence and survival from OHCA varies considerably both between countries and 
within countries. The EuReCa ONE study of 10,672 OHCAs in 27 European countries 
during October 2014 reported an incidence of emergency medical services (EMS)-
treated OHCA of 19.0 to 104.0 per 100,000 people per year, and an overall survival 
to hospital discharge of 10.3% [1]. The North American Resuscitation Outcomes 
Consortium (ROC) reported an incidence of EMS-treated OHCA of 73.0 (95% CI 71.2 
to 74.7) per 100,000 adults per year in 2014/15 with an overall survival to hospital 
discharge of 11.4% (95% CI 10.4 to 12.4%) [2]. EMS-treated cardiac arrests account 
for about half of the OHCA attended by and assessed by EMS at ROC sites [3]. The 
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US Cardiac Arrest Registry to Enhance Survival (CARES) database of 132 U.S. counties 
reported widely variable survival to hospital discharge rates of 3.4 to 22.0% [4]. Some 
of these differences can be attributed to differences in healthcare systems, the 
quality of the local chain of survival, patient factors, and differences in how OHCA 
data is collected and reported. The recognition that there is potential to save many 
more lives from cardiac arrest has led to national strategies in some countries to 
improve outcome from OHCA [5, 6].  
 
Studies suggest care and outcomes after OHCA are improving. In Denmark, the 
incidence of EMS-treated OHCA from a primary cardiac cause decreased from 40 
to 34 per 100,000 people, and 30-day survival increased from 3.5 to 10.8% between 
2001 and 2010 [7]. This improvement was associated with an increase in bystander 
CPR rates. Between 2001 and 2012 the Danish rate of bystander CPR among 30-day 
survivors increased from 66.6% to 80.6% (P < 0.0001), and the rate of bystander 
defibrillation among 30-day survivors increased from 2.1% to 16.8% (P < 0.0001)[8]. 
The North American ROC reported that between 2006 and 2010, survival to 
discharge after OHCA increased from 8.2% to 10.4% [3]. The best outcomes occur in 
patients with a witnessed primary cardiac arrest and an initial shockable rhythm 
(ventricular fibrillation/pulseless ventricular tachycardia– VF/pVT). Recent London 
Ambulance Service data show survival to hospital discharge for these patients has 
increased from 5% in 2001/2, to 12% in 2007/8, and to 31.5% in 2015/16 [9].  
 
After return of spontaneous circulation (ROSC), most OHCA survivors are comatose 
or have another indication for tracheal intubation and mechanical ventilation [10, 
11]. Retrospective UK data from the Intensive Care National Audit and Research 
Centre (ICNARC) between 2004 and 2014 showed that survivors of OHCA (n= 29,621) 
accounted for an increasing proportion of all mechanically ventilated admissions to 
ICUs (3.5 % in 2004, 5.8 % in 2014) [12]. Risk-adjusted hospital mortality following 
admission to ICU after in-hospital cardiac arrest (IHCA) and OHCA combined 
decreased significantly during this period (OR 0.96 per year). An Australian study of 
3449 OHCA survivors between 2000 and 2014 reported a mean survival of 11.9 years, 
and a one-, 10-, and 15-year survival of 92.2%, 70.1% and 62.3% respectively [13]. 
After 5 years the standardised mortality rate for survivors was similar to the general 
population.  
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The quality of survival after cardiac arrest is most commonly assessed using the 
Cerebral Performance Category (CPC) or Modified Rankin Scale (mRS) with a CPC 
of 1–2 or a mRS of 0–3 considered a good neurological outcome. CARES data for 
2015 showed that 81% of those surviving to hospital discharge had a CPC score of 1 
or 2 [2]. Although most survivors have a good CPC or mRS outcome, these scales do 
not identify more subtle impairments in cognitive function or impairments in 
functional outcomes.  
 
Importantly, CPC and mRS improve in survivors over time. In Denmark, 610 (76.6%) of 
the 796 cardiac arrest survivors between 2001 and 2011, who had been employed 
before their cardiac arrest returned to work in a median time of 4 months [14]. The 
proportion of survivors returning to work increased over time, from 66.1% in 2001–2005 
to 78.1% in 2006–2011 (P = 0.002). When 287 survivors of OHCA from the TTM study 
were compared with 119 matched control patients with ST-segment-elevation 
myocardial infarction (STEMI) without OHCA at 180 days, attention/mental speed 
was more affected among cardiac arrest patients, but memory and executive 
functioning were similar [15]. The OHCA survivors also reported a more restricted 
societal participation and a lower return to work [16]. The Parisian registry compared 
health-related quality of life (HRQOL) data at a median of 50 months in 255 OHCA 
survivors with the general population using the Short Form 36 (SF-36) questionnaire 
[17]. In CPC 1 patients HRQOL was similar to age and gender matched controls in 
the general population whereas those with worse neurological outcomes (CPC 2 or 
3) also had a worse HRQOL across most SF-36 dimensions. 
 
[h1] Disparities in organisation and outcome  
[h2] Variations in community response 
Although several studies show a marked variation in OHCA survival across countries 
and regions, factors underlying this outcome variation remain incompletely 
explained  [1, 4, 18, 19]. These geographical disparities in outcome may be 
associated with factors affecting each link in the chain of survival. A substantial 
proportion of the variation across countries seems to reflect differences in bystander 
response across communities (Table 1). Social economic and education disparities 
could explain some of this variation. In Australia, significant heterogeneity in rates of 
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bystander-CPR and survival have been documented across rural and metropolitan 
regions [20]. Neighbourhood characteristics may influence rates of bystander-
initiated CPR. A large US cohort study (n=14 225) showed that patients who had an 
OHCA in low-income black neighbourhoods were less likely to receive bystander-
initiated CPR than those in high-income white neighbourhoods [21]. This was 
confirmed in a recent study which documented that the lowest rates of bystander 
CPR and AED use occurred in predominantly black neighbourhoods and that these 
neighbourhoods had significantly lower likelihood for OHCA survival compared with 
predominantly white neighbourhoods [22]. Improving bystander interventions in 
these neighbourhoods may improve cardiac arrest survival. In a cross-sectional 
telephone survey, lesser education and lower income were associated with 
reduced likelihood of CPR training, illustrating the need to develop tailored CPR 
education to address this variability [23]. Language barriers for comprehension and 
implementation of telephone-CPR were also identified. In a recent US study that 
focused on Spanish-speaking callers, the average time for the dispatcher to 
recognize need for CPR was two-times longer than with English-speaking callers, and 
it resulted in longer delays to first compression [24]. 
 
[Insert table 1 near here] 
 
[h2] Variations in emergency medical services systems 
There are marked differences in the organisation of EMS, but it is unclear if this 
contributes to disparities in OHCA outcome. Ambulance crews using advanced life 
support (ALS) are staffed and equipped to provide sophisticated care on site, 
whereas basic life support (BLS) gives priority to rapid transport with only minimal 
treatment at the scene. The ALS crews can provide more sophisticated interventions, 
such as tracheal intubation for airway management and intravenous catheters for 
drug and fluid delivery, but they spend more time at the scene on average and 
their cost is higher. In a multicentre, controlled clinical trial conducted in 17 
Canadian cities and enrolling 5638 OHCA patients, the implementation of ALS 
interventions did not improve the rate of survival [25]. More recently, several studies 
have questioned the usefulness of ALS interventions in OHCA, including airway 
management [26, 27], adrenaline (epinephrine)[28, 29], or anti-arrhythmic drugs 
[30]. In many parts of the world, ALS ambulances are also staffed with a physician 
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specialist in emergency medicine. One study that used propensity analysis 
documented that the presence of a physician on the ambulance was associated 
with better short and long-term outcome after OHCA [31] but other studies have 
failed to show benefit for prehospital physicians [32]. The findings of a recent 
systematic review were consistent with this benefit and suggested that physician-
guided resuscitation may improve survival outcomes after OHCA [33] but the cost-
effectiveness of this policy is controversial.  
 
[h2] Regionalisation of cardiac arrest care 
The wide disparities in outcome across institutions receiving OHCA patients led the 
American Heart Association (AHA) to recommend in 2010 the implementation of 
regional cardiac resuscitation centres for post-resuscitation care following OHCA 
[34]. This AHA policy stated that the essential elements of a ‘Level 1’ cardiac arrest 
centre should encompass an extensive experience with targeted temperature 
management (TTM), a 24 h/day capability for cardiac catheterisation laboratory, 
advanced haemodynamic support and treatment of re-arrest, the ability to perform 
electrophysiology testing and defibrillator assessment and placement, processes to 
ensure appropriate timing and methods of neurological prognostication, and finally 
a comprehensive multidisciplinary performance improvement program to 
continuously track outcomes [34]. In Arizona, implementation of a system of cardiac 
arrest centres (bypassing smaller hospitals) was independently associated with 
increased overall survival and favourable neurological outcome, particularly among 
patients with witnessed shockable rhythms [35]. Outside of US, the concept of 
cardiac arrest centres, although being informally accepted, is not firmly established 
and implemented. In the UK, for example, only 13% of acute hospitals could meet 
these requirements [36]. 
 
Considering the uncertainty about disparities in outcome, there is an urgent need for 
establishing national and international comparisons focusing in particular on public 
education, EMS organisation and cardiac arrest pathways. This may come from 
large registries that should be supported by health authorities. 
 
[h1] Recent advances and ongoing controversies in cardiopulmonary resuscitation 
[h2] Recent advances in the community response 
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Bystander CPR increases 30-day survival from OHCA by 2–3 times [37, 38]. Many EMS 
systems around the world have implemented telephone CPR systems whereby the 
dispatcher guides the bystander to provide chest compressions while awaiting 
arrival of EMS personnel. These telephone systems can significantly increase 
bystander CPR rates, survival to hospital discharge and survival with good 
neurological outcome [39-41]. Use of smart phones, which are generally equipped 
with Global Positioning System (GPS) technology, enables trained volunteers within 
500–1000 m of a cardiac arrest to be dispatched by short message system (SMS) 
messages (Figure 2). In a randomised controlled trial involving 667 OHCAs such a 
system increased the rate of bystander CPR from 48% to 62% (p<0.001) [42]. Since 
use of public access AEDs improve outcome [43], such GPS systems can also be 
used to guide volunteer responders to retrieve a nearby AED. This enables even 
faster defibrillation [44], but is dependent on the location of public access AEDs 
being registered with the local EMS. Unfortunately, the location of such AEDs is often 
unknown to the EMS, and this must be updated in the future. Finally, the use of 
drones to deliver AEDs to the scene of a cardiac arrest has been evaluated and has 
been shown to be feasible [45].  
 
INSERT Figure 1 near here 
 
The impact on outcome of ALS interventions remains unclear for both OHCA and 
IHCA. The optimal airway management technique is likely to vary during the 
resuscitation attempt and will depend on the skills of the rescuers and 
practice/logistics within each system. A randomised clinical trial of tracheal 
intubation versus bag-mask ventilation in OHCA (with intubation delayed until after 
ROSC) undertaken by prehospital physicians in France and Belgium showed no 
difference in favourable neurological outcome at 28 days [26]. Two recently 
completed but unpublished cluster randomised trials of a supraglottic airway (SGA) 
versus tracheal intubation will provide further data on airway management in OHCA 
[46, 47]. 
 
In a randomised trial in 851 OHCA patients, use of intravenous drugs following the 
existing guidelines compared with no use of drugs had no significant effect on long 
term outcome [48]. The impact of adrenaline on long-term outcome after cardiac 
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arrest has never been evaluated in an appropriately powered randomised 
controlled trial. A single under-powered randomised controlled trial and 14 
observational studies which compared adrenaline (1 mg every 3–5 minutes) with no 
adrenaline indicate that the rate of ROSC is doubled (19.7% versus 5.5%; OR 2.85 
(95% CI 2.28–3.54) but fewer patients survived with favourable neurological 
outcomes (1.9% versus 2.2%; OR 0.51 (95% CI 0.31–0.84) [49, 50]. An RCT comparing 
adrenaline with placebo in OHCA has just completed enrolment of over 8000 
patients but has yet to be published [51].  
 
Mechanical CPR devices enable high-quality CPR to be provided for prolonged 
periods and during transport. However, meta-analysis of five RCTs comparing 
mechanical CPR with manual CPR found no significant improvement in initial 
survival, survival to discharge / 30 days (odds ratio (OR) 0.89, (95% confidence 
interval (CI) 0.77- 1.02)) or favourable neurological outcome (OR 0.76, (95% CI 0.53, 
1.11)) [52]. Despite these neutral studies, the use of mechanical CPR devices is still 
recommended for prolonged CPR, during transport to more advanced in-hospital 
treatment (e.g., extracorporeal-CPR (E-CPR)) or during interventions in the cardiac 
catheterisation laboratory [53]. 
 
Extracorporeal CPR in the form of veno-arterial extracorporeal membrane 
oxygenation (VA-ECMO) is being implemented in many healthcare systems. A 
systematic review and meta-analysis of observational data documented an 
association between use of E-CPR and an increase in survival and favourable 
neurological outcome [54]. There are significant challenges posed in implementing 
E-CPR, not least cost and local expertise in the technique. Outcomes are likely to be 
optimised by adhering strictly to evidence-based inclusion and exclusion criteria [55, 
56]. 
 
[h1] Post-resuscitation care: current practice and ongoing controversies 
[h2] Coronary angiography 
In patients resuscitated from OHCA without an obvious non-cardiac cause the 
prevalence of an acute coronary artery lesion ranges from 59 to 71% [57].  
Observational evidence shows that in resuscitated OHCA of suspected cardiac 
origin with ST segment elevation (STE) or left bundle branch block on post-ROSC 
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electrocardiogram (ECG) emergent coronary angiography and PCI when 
appropriate are associated with increased survival and favourable neurological 
outcome, and it is currently recommended [57]. In patients without STE on the post-
ROSC ECG the potential benefits of early invasive management are currently under 
investigation in several randomised trials (NCT02309151, NCT02387398, NCT02750462). 
In patients with refractory OHCA from VF/pVT and admitted to hospital with ongoing 
CPR, an early invasive management bundled with E-CPR resulted in 42% rate of 
survival to discharge with good neurological outcome [58].  
 
[h2] Targeted temperature management 
Fever is common after CA and it is mainly related to an inflammatory response 
during the reperfusion phase. Targeted temperature management (TTM) at 33–36 °C 
is a key element of post-resuscitation care and it can be achieved using both 
invasive and non-invasive techniques [59]. There is inconclusive evidence whether 
any temperature target is better than the other and there is variation in practice 
throughout Europe [60] as well as North America. If the target is 36°C, efforts should 
be made to stay within target and avoiding higher temperatures [61]. The 
recommended duration of TTM should be at least 24 hours [62]. In unconscious 
survivors of OHCA, TTM at 33oC for 48 hours did not significantly improve 6-month 
neurological outcome compared with TTM for 24 hours [62]; however, survival was 
very high in both groups. The phase 3 TTM-2 trial has just started recruiting and is 
comparing comatose post OHCA patients treated with TTM at 33oC versus standard 
care avoiding fever (≤ 37.8oC) (NCT02908308). Cardiac arrest patients are complex 
and heterogeneous, and it is likely that the optimal treatment strategy will depend 
on the cause of cardiac arrest, the severity of the reperfusion injury and the 
haemodynamic status of each patient. The evidence for the use of TTM after IHCA is 
inconclusive, and intensivists should use clinical judgement when applying TTM for 
IHCA patients [63].  
 
[h2] Oxygenation targets 
Observational evidence suggests that extreme hyperoxia (PaO2 >300 mmHg or 40 
kPa) after CA may be harmful [64]. In an RCT involving patients with prehospital 
STEMI, but not cardiac arrest, routine oxygen therapy compared with oxygen only if 
SpO2 < 94% resulted in significantly larger infarct size [65]. In another recent RCT of 
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more than 6000 patients with suspected acute myocardial infarction (AMI), oxygen 
6 lpm for 6–12 h compared with air did not reduce death at 365 days, the primary 
endpoint [66]. A Phase 3 study (EXACT) involving titration of oxygen to a target SpO2 
90–94% as soon as possible after ROSC in OHCA has just started recruiting 
(NCT02499042). Pending the results of this trial, the inspired fraction of oxygen after 
ROSC should be titrated to maintain the arterial blood oxygen saturation in the 
range of 94–98 % [57].  
 
[h2] Post-resuscitation ventilation 
Hypercapnia is common immediately after ROSC, while iatrogenic hypocapnia due 
to hyperventilation may occur especially during TTM and worsen cerebral ischaemia 
[67]. Hypercapnia might increase blood flow to ischaemic brain and observational 
studies have documented an association between mild hypercapnia and better 
neurological outcome [68, 69] and better cerebral oxygenation [70] among post 
cardiac arrest patients. A phase 2 study comparing mild hypercapnia with 
normocapnia in 50 post arrest patients documented a lesser increase in neuron 
specific enolase (NSE) values in the hypercapnia group [71]. A Phase 3 study (TAME) 
of normocapnia versus mild hypercapnia (6.6–7.3 kPa (50–55 mmHg)) in post-
cardiac arrest patients will soon start recruiting (NCT03114033). Current 
recommendations are that ventilation should be titrated to target normocapnia 
[57]. A protective lung ventilation (tidal volume 6–8 ml kg-1 ideal body weight and 
positive end expiratory pressure 4–8 cm H2O) is recommended and may be 
beneficial in OHCA patients [72]. 
 
[h2] Blood pressure targets 
Intensivists often will control the blood pressure with vasoactive medicines, but the 
optimal target is not clear. Each individual probably has different minimum pressures 
for adequate perfusion of various organs based on their history of hypertension and 
current vascular tone. Cerebral autoregulation is disturbed in a third of comatose 
post-cardiac arrest patients [73] and optimal perfusion of the injured brain may 
require higher mean arterial pressures (perhaps 85–100 mmHg) than typically 
selected in non-brain injured patients (>65 mmHg) [74]. 
 
[h2] Prognostication 
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Two-thirds of deaths occurring in patients who are admitted comatose to ICU after 
ROSC follow withdrawal of life-sustaining treatment (WLST) because of presumed 
irreversible hypoxic-ischaemic brain injury (HIBI) [75]. Ensuring optimal 
prognostication is essential to avoid potential harm resulting from an inappropriate 
WLST. Before prognostic assessment is made, major confounders – such as residual 
sedation or neuromuscular blockade – should be excluded and, for this reason, 
using short-acting drugs is preferable [76]. In patients who are unconscious with 
absent or extensor motor response to pain at 72 hours or more after ROSC, a 
bilateral absence of N20 wave of somatosensory evoked potentials and/or bilateral 
absent pupillary response to light predicts severe neurological disability or death 
with <5% false positive rate and narrow confidence intervals [57]. When these signs 
are absent, a combination of two or more among early status myoclonus, high 
blood values of NSE, or signs of severe HIBI on brain computed tomography or EEG 
also suggests a poor neurological outcome, but the confidence in this prediction will 
be lower. If none of these conditions is present, the prognosis is indeterminate, and 
further observation is indicated. This can be prolonged, since delayed awakening is 
common in patients with an eventually good outcome after cardiac arrest [77].  
 
Acquired brain injury patients who have early (first week) mobilisation and 
rehabilitative interventions show more improvement in functional measures than 
patients without early mobilisation [78]. 
 
 
Future directions  
Priority areas for future research in cardiac arrest have been defined recently [79, 
80]. Adequately-powered randomised trials are the gold standard for evidence of 
the efficacy and effectiveness as well as implementation of interventions in patients 
with acute cardiovascular conditions. Randomised controlled trials for efficacy are 
relatively rare in resuscitation science.  Even so, when a treatment, an intervention or 
a system of care change is based on the highest level of evidence, adoption and 
widespread implementation takes time.  Several factors reduce the rate of 
evidence-based change in clinical practice related to treatment of patients with 
OHCA. Some of these factors may be modifiable by clinicians, researchers and 
policy makers. 
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The first modifiable factor is the lack of resources dedicated to support high-quality 
randomised trials in resuscitation (Table 2). Resources for health care research are 
limited. Cardiac arrest research is underfunded compared to other clinical disorders 
[81]. The Resuscitation Outcomes Consortium (ROC) was a North American multi-
center clinical research network designed to conduct clinical out-of-hospital trials of 
therapies for cardiac arrest and major trauma. Over a ten-year period, communities 
that participated in ROC observed a doubling of survival after OHCA [3, 82]. This 
suggests that outcomes after OHCA can be improved, and that further investments 
in research and implementation warrant consideration. Multinational collaborations 
will facilitate the rate of recruitment into randomised trials and is a strategy being 
increasingly adopted in resuscitation research. 
 
Insert Table 2 near here 
 
The second modifiable factor that would facilitate the implementation of 
randomised trials in resuscitation is global uniformity in the approach to enabling 
trials to use waiver of informed consent. Patients in cardiac arrest cannot provide 
individual consent before they are enrolled in a clinical trial. There is considerable 
variation in policies and procedures related to exemption from informed consent for 
emergency research [83, 84]. In some settings, waiver of consent is not permitted, 
and the investigator must seek, deferred consent or consent may be required for 
ongoing participation in a clinical trial. Either approach may introduce bias if those 
who consent have different baseline characteristics or outcome as compared to 
those who do not [85]. 
 
A third modifiable factor is the analytical approach for cardiac arrest trials.  Overall, 
survival after OHCA with any initial rhythm is low. Traditionally randomised 
resuscitation trials use fixed sample size to compare the effect of one or more 
interventions compared to standard care. Ordinarily such trials use logistic regression 
to evaluate survival to discharge or good neurologic status at discharge. Fixed or 
group sequential methods may require many subjects to detect a clinically 
important difference in such binary outcomes because of the low overall rate of 
success after resuscitation. As a consequence, some recent randomised trials have 
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sought to enroll several thousand subjects or more over several years to detect the 
minimum clinically important difference in survival [51, 86]. There is a need to 
accelerate the processes and efficiency of future trials. Adaptive trial designs which 
use accumulating data to inform changes to the study as it progresses may 
accelerate generation of knowledge and reduce cost [87]. However, this may be at 
the expense of the reliability of the treatment estimates derived from the trial [88]. 
Bayesian approaches which make use of prior information can be used to provide a 
quantitative summary of treatment effect when traditional approaches for defining 
statistical significance are impractical [89]. Registry-based trials and trials which 
obtain follow-up data through administrative data sources may reduce the burden 
and cost of data collection [90, 91]. These are very challenging to do well and meet 
the privacy and ethical concerns which appear to evolve often across legislations 
[92].  
 
The fourth modifiable approach to randomised cardiac arrest trials is the definition 
of the primary outcome of interest. Traditionally most trials have measured survival to 
hospital discharge as this measure is convenient, least costly and unbiased. 
Neurological favourable outcome at discharge or 30 days is also a useful measure 
and is collected in many OHCA trials. The use of hospital-free survival, assessed as 
the number of days alive and out of hospital during the first thirty days post arrest 
may provide statistical efficiency over dichotomous outcomes such as survival and 
favourable neurological outcome [93]. Although this is measurable and may reduce 
sample size requirements in costly randomised trials, like progression-free survival in 
cancer, there is controversy about the usefulness of this measure in cardiac arrest 
trials [94, 95]. 
 
Outcomes preferred by investigators may not be what is important to patients. Trials 
involving critically ill patients rarely measure patient reported outcomes as the 
primary or secondary outcome measure (5% vs 22% respectively) [96]. Patients and 
their family members involved in the Core Outcomes Set for Cardiac Arrest (COSCA) 
process identified survival, neurological function and health-related quality of life as 
the preferred outcome measure [97]. To date, studies of post-discharge outcomes 
have provided conflicting evidence of the magnitude of impairment after cardiac 
arrest [15, 86, 98, 99]. These discordant results may partly reflect difference in the 
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timing and method of measurement. Proximate assessments are easier to obtain but 
may not fully reflect patient recovery; downstream assessments may more fully 
reflect recovery but are harder to obtain, add significantly to the cost of the trial 
and delay study completion.  
 
The final modifiable factor is the need to have a translation or implementation 
component to each randomised trial. Many granting agencies include a 
knowledge translation requirement for all grants hoping to move the responsibility for 
scientific advancements from bench to bedside into the hands of the investigator.  
This intervention alone has not had an impact and there are large delays in 
implementation. The emphasis appears to be shifting to those responsible for 
publishing guidelines and making policy [100]. The International Liaison Committee 
on Resuscitation (ILCOR) is moving to a continuous evidence review process where 
systematic reviews of high priority research questions are posted and council 
guidelines will change accordingly (www.ilcor.org) [101]. This may not be enough for 
policy to change. Scaling up and spread of effective health interventions may 
require a more novel approach of partnerships [102]. We anticipate that 
partnerships between ILCOR, the World Health Organization and the Global 
Resuscitation Alliance, for example, might generate the impetus for change. 
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[h1] Legends 
Figure 1. A text message (TM) alert system in North Holland. When a dispatcher 
suspects an out-of-hospital cardiac arrest, trained first responders within 1000 m are 
alerted to either first retrieve an automated external defibrillator (if within 500 m) and 
then go to the victim or to go directly to the victim and start CPR [44]. Reproduced 
with permission from Resuscitation. 
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